68Ga-PMD22 PET/CT Examination Targeting CLDN18.2
NCT05937919
·
clinicaltrials.gov ↗
EARLY_PHASE1
Phase
UNKNOWN
Status
10
Enrollment
OTHER
Sponsor class
Conditions
Gastrointestinal Cancer
Interventions
DRUG:
Intravenous injection of 68Ga-PMD22
Sponsor
Peking Union Medical College Hospital